Skip to content

Investors and News

Seres' news, events and other information can be found throughout the pages below.

Investors and News

Corporate Profile

Seres Therapeutics is a late-clinical-stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human microbiome.

Read More


Data Provided by Refinitiv. Minimum 15 minutes delayed.

Shareholder Tools